Rob Woolfenden II
Advertisement
Rob Woolfenden II is principal engineer in the process development department at Amgen, Inc.
Articles by Rob Woolfenden II
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
